trodelvy
gilead sciences ireland uc - sacituzumab govitecan - breast neoplasms; triple negative breast neoplasms - antineoplastilised ained - trodelvy as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic triple-negative breast cancer (mtnbc) who have received two or more prior systemic therapies, including at least one of them for advanced disease.
nytyka pehmekapsel
norameda uab - nintedaniib - pehmekapsel - 150mg 60tk; 150mg 30tk
nintedanib stada pehmekapsel
stada arzneimittel ag - nintedaniib - pehmekapsel - 150mg 60tk; 150mg 30tk
nintedanib zentiva pehmekapsel
zentiva k.s. - nintedaniib - pehmekapsel - 150mg 60tk; 150mg 30tk
nintedanib zentiva pehmekapsel
zentiva k.s. - nintedaniib - pehmekapsel - 100mg 60tk; 100mg 30tk
nintedanib teva pehmekapsel
teva gmbh - nintedaniib - pehmekapsel - 150mg 30tk; 150mg 60tk
nintedanib teva pehmekapsel
teva gmbh - nintedaniib - pehmekapsel - 100mg 30tk; 100mg 60tk
nintedanib stada pehmekapsel
stada arzneimittel ag - nintedaniib - pehmekapsel - 100mg 30tk